Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(4-methanesulfonylbenzyl)-2-methyl-1h-pyrrolo(2,3-b)pyridin-3-yl)acetic Acid
2. Nvp-qaw039
1. 872365-14-5
2. Nvp-qaw039
3. Qaw039
4. Fevipiprant [inn]
5. 2pex5n7dq4
6. Fevipiprant(nvp-qaw039)
7. Qaw-039
8. 2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[2,3-b]pyridin-3-yl]acetic Acid
9. (1-(4-((methane)sulfonyl)-2-trifluoromethylbenzyl)-2-methyl-1h-pyrrolo(2,3-b)pyridin-3-yl)acetic Acid
10. 2-(1-((4-methanesulfonyl-2-(trifluoromethyl)phenyl)methyl(-2-methyl-1h-pyrrolo(2,3-b)pyridin-3-yl)acetic Acid
11. 2-(2-methyl-1-(4-(methylsulfonyl)-2-(trifluoromethyl)benzyl)-1h-pyrrolo[2,3-b]pyridin-3-yl)acetic Acid
12. 2-methyl-1-[[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl]-1h-pyrrolo[2,3-b]pyridine-3-acetic Acid
13. Fevipiprant [usan:inn]
14. Unii-2pex5n7dq4
15. Qaw 039
16. Fevipiprant [jan]
17. Fevipiprant [usan]
18. Fevipiprant [who-dd]
19. Fevipiprant (jan/usan/inn)
20. Gtpl8995
21. Schembl1940595
22. Chembl3137332
23. Dtxsid501336031
24. Hms3743e19
25. Bcp25015
26. Ex-a2495
27. Bdbm50233520
28. Mfcd22548206
29. Zinc43101772
30. Ab85348
31. Cs-5956
32. Db12011
33. Fevipiprant; Nvp-qaw039; Qaw039
34. Sb16897
35. Ac-31956
36. As-74870
37. Hy-16768
38. Ds-022511
39. Ft-0774596
40. D10631
41. Q27077292
42. 1-(4-methanesulfonylbenzyl)-2-methyl-1h-pyrrolo(2,3-b)pyridin-3-yl)acetic Acid
43. (2-methyl-1-{[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl}-1h-pyrrolo[2,3-b]pyridin-3-yl)acetic Acid
44. [1-(4-methanesulfonyl-2-trifluoromethyl-benzyl)-2-methyl-1h-pyrrolo[2,3-b]pyridin-3-yl]-acetic Acid
45. [2-methyl-1-[4-(methylsulfonyl)-2-(trifluoromethyl)benzyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]acetic Acid
46. 2-(1-{[4-methanesulfonyl-2-(trifluoromethyl)phenyl]methyl}-2-methyl-1h-pyrrolo[2,3-b]pyridin-3-yl)acetic Acid
47. 2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[5,4-b]pyridin-3-yl]acetic Acid
48. Fsy
Molecular Weight | 426.4 g/mol |
---|---|
Molecular Formula | C19H17F3N2O4S |
XLogP3 | 2.8 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 5 |
Exact Mass | 426.08611269 g/mol |
Monoisotopic Mass | 426.08611269 g/mol |
Topological Polar Surface Area | 97.6 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 709 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Treatment of asthma
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?